Medicines losing patent protection

MonthYear

April 2027

4 medicines lose their last listed patent or exclusivity in April 2027.

Apr 13Oxtellar XRoxcarbazepine · Supernus Pharmaceuticals Inc
Apr 24Clinolipid 20%olive oil and soybean oil · Baxter Healthcare Corp
Apr 25Chloraprep One-Stepchlorhexidine gluconate and isopropyl alcohol · Becton Dickinson and Co
Apr 30Amyvidflorbetapir F-18 · Avid Radiopharmaceuticals Inc

Dates are the patent and exclusivity end dates listed in the FDA's Orange Book, in its data up to October 9, 2026. Patents can be extended, challenged in court or settled, so a generic may come earlier, later or not at all. This is not legal or medical advice.

About the data·Privacy·Credits